ロード中...
Mesenchymal stem cell therapy in type 2 diabetes mellitus
Type 2 diabetes mellitus (T2DM), which is characterized by the combination of relative insulin deficiency and insulin resistance, cannot be reversed with existing therapeutic strategies. Transplantation of insulin-producing cells (IPCs) was once thought to be the most promising strategy for treating...
保存先:
| 出版年: | Diabetol Metab Syndr |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5433043/ https://ncbi.nlm.nih.gov/pubmed/28515792 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13098-017-0233-1 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|